FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/081910 [Registered on: 07/03/2025] Trial Registered Prospectively
Last Modified On: 21/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Bone Graft with and without Spirulina Gel in Treating Bone Defect: A Clinical Trial 
Scientific Title of Study   Comparative Evaluation of Demineralised Freeze-Dried Bone Allograft with and without Spirulina Gel in the treatment of Class II Furcation Defects: A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tasneem Azad 
Designation  Post-Graduate Student 
Affiliation  Ranjeet Deshmukh Dental College and Research Center 
Address  104, Dept of Periodontology and Implantology Ranjeet Deshmukh Dental College and Research Center Digdoh Hills, Higna Road, Nagpur-440019

Nagpur
MAHARASHTRA
440019
India 
Phone  07773945522  
Fax    
Email  tasneemazad3@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dhawal Mody 
Designation  Reader and Guide 
Affiliation  Ranjeet Deshmukh Dental College and Research Center 
Address  104, Dept of Periodontology and Implantology,Ranjeet Deshmukh Dental College and Research Center Digdoh Hills, Higna Road, Nagpur-440019

Nagpur
MAHARASHTRA
440019
India 
Phone  8055775977  
Fax    
Email  periowell@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Dhawal Mody 
Designation  Reader and Guide 
Affiliation  Ranjeet Deshmukh Dental College and Research Center 
Address  104, Dept of Periodontology and Implantology,Ranjeet Deshmukh Dental College and Research Center Digdoh Hills, Higna Road, Nagpur-440019

Nagpur
MAHARASHTRA
440019
India 
Phone  08055775977  
Fax    
Email  periowell@gmail.com  
 
Source of Monetary or Material Support  
104,Department of Periodontics and Implantology,Ranjeet Deshmukh College and Research center Nagpur-440019 India 
 
Primary Sponsor  
Name  self 
Address  104, Dept of Periodontology and implantology,Ranjeet Deshmukh Dental College and research center Nagpur-440019 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Dhawal Mody  Ranjeet Deshmukh Dental College and Research Center  104, Department of Periodontics and Implantology Nagpur,MAHARASHTRA
Nagpur
MAHARASHTRA 
08055775977

periowell@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ranjeet Deshmukh Dental College and Research Centre Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  DFDBA alone  Stage III Periodontitis patients aged 30 - 60 years exhibiting 25 Class Il furcation defects to be treated with DFDBA and bone graft alone. 
Intervention  Spirulina gel with DFDBA  Stage III Periodontitis aged 30 to 60 patients exhibiting 25 Class Il furcation defects to be treated with spirulina gel with DFDBA Intervention Frequency -one time at the site  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)Patients with stage III Periodontitis as assessed by Probing Pocket Depth (PPD) more than or equal to 6mm ,interdental clinical attachment level (CAL) more than or equal to 5 mm and Horizontal Probing Depth (HPD) more than or equal 2mm.
2) Bilateral buccal or lingual Class II furcation involvement
 
 
ExclusionCriteria 
Details  1.Patients with history of systemic diseases, allergies or drug usage.
2.Patients who have undergone periodontal treatment in previous 6 months.
3.Pregnant and lactating females.
4.Smokers or tobacco chewers 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate and compare the effectiveness of DFDBA with and without Spirulina gel in the treatment of Class II Furcation defects clinically and radiographically by CBCT.   at baseline,3 months and 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
1. Assess clinical parameters (CAL, PPD, HPD) in Class II furcation defects treated with Spirulina gel + DFDBA and DFDBA alone.
2. Evaluate radiographic bone fill using CBCT in defects treated with Spirulina gel + DFDBA and DFDBA alone.
3. Compare the clinical and radiographic outcomes between Spirulina gel + DFDBA and DFDBA alone over time. 
baseline, 3, and 6 months.  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study will include patients visiting the department of Periodontics and Implantology diagnosed with Stage III Periodontitis and exhibiting Class II furcation defects. Two sites in each patient will be assigned randomly for sampling.

It will be conducted in Department of Periodontics and Implantology, after taking informed consent from the patient. All the clinical and radiographical parameters will be evaluated at baseline after which the sites in the patients will be randomly and equally divided into Test and Control groups to be treated with Spirulina gel with DFDBA and DFDBA alone respectively in Class II furcation defects in Stage III Periodontiits patients. The study will be initiated after clearance from the Institutional Ethics Committee. For each patient two sites will be randomly assigned as;

Group I: (Control Group) – Stage III Periodontitis exhibiting bilateral Class II furcation defects to be treated with DFDBA alone.

Group II: (Test Group) - Stage III Periodontitis exhibiting bilateral Class II furcation defects to be treated with DFDBA with Spirulina gel.

 

Pre-surgical Hygiene

Therapy Initial therapy will consist of detailed oral hygiene instructions and Scaling and root planing. Prior to initiating the study, its purpose and design will be explained and written informed consent will be signed by every patient.

Surgical procedure: Under local anaesthesia, full thickness mucoperiosteal flaps will be reflected and granulation tissue will be debrided. The root surfaces will be scaled and planed. In Group I the Class II furcation defects will be treated with DFDBA alone while in Group II the Class II furcation defects will be treated using DFDBA with Spirulina gel. The flaps will be sutured back to their original position. Periodontal dressing will be placed at the surgical sites.

Post-surgical Care: Patient will be placed on antibiotics and analgesics. Sutures will be removed after 7 days. Clinical results will be evaluated at 3 and 6 months post-operatively and radiographic evaluation will be performed at 6 months post-operatively by CBCT.

 


 
Close